InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（6 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
6
T+90 胜率
100%
T+90 平均收益
+16.1%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the complete record of transactions filed by Lalwani Nikhil, 董事长兼首席执行官. Officer active across 1 company, notably ANI Pharmaceuticals INC. In total, 34 filings have been logged. Breakdown: 1 buy · 6 sells. Total volume traded: €11.1m. History available since 8 September 2021. The latest transaction was filed on 25 August 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Lalwani Nikhil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报34 总计
5,400 股@ US$74.30Common StockSEC:0001822629-26-000014:0
17,060 股@ US$74.040.061% mcap6.3% 占其流量Common StockSEC:0001822629-26-000008:0
75,592 股@ US$77.1517.5% 占其流量Common StockSEC:0001822629-26-000006:0
11,688 股@ US$76.704.4% 占其流量Common StockSEC:0001822629-26-000004:0
10,298 股@ US$77.363.9% 占其流量Common StockSEC:0001822629-26-000004:1
30,659 股@ US$76.257.0% 占其流量Common StockSEC:0001822629-26-000002:0
56,960 股@ US$85.9319.6% 占其流量Common StockSEC:0001822629-25-000010:0
17,455 股@ US$64.266.0% 占其流量Common StockSEC:0001822629-25-000008:0
17,060 股@ US$60.625.6% 占其流量Common StockSEC:0001822629-25-000006:0
12,216 股@ US$61.894.2% 占其流量Common StockSEC:0001822629-25-000004:0
7,799 股@ US$58.922.5% 占其流量Common StockSEC:0001822629-25-000002:2
91,399 股0Common StockSEC:0001822629-25-000002:0
60,932 股0Common StockSEC:0001822629-25-000002:1
30,000 股@ US$29.004.8% 占其流量Common StockSEC:0001822629-24-000014:0
3,646 股@ US$60.511.2% 占其流量Common StockSEC:0001822629-24-000012:0
16,669 股@ US$66.105.9% 占其流量Common StockSEC:0001822629-24-000010:0
17,455 股@ US$69.586.5% 占其流量Common StockSEC:0001822629-24-000008:0
28,965 股@ US$65.5210.1% 占其流量Common StockSEC:0001822629-24-000006:0
10,014 股@ US$67.673.6% 占其流量Common StockSEC:0001822629-24-000004:0
80,530 股0Common StockSEC:0001822629-24-000002:0
3,646 股@ US$61.941.2% 占其流量Common StockSEC:0001822629-23-000004:0
56,666 股@ US$57.7517.3% 占其流量Common StockSEC:0001822629-23-000002:0
11,616 股@ US$29.001.8% 占其流量Common StockSEC:0001822629-23-000002:1
11,616 股@ US$61.133.8% 占其流量Common StockSEC:0001822629-23-000002:2
95,530 股0Common StockSEC:0001104659-23-041742:0
34 条申报中的 25 条
About Lalwani Nikhil
Lalwani Nikhil is President & CEO at ANI Pharmaceuticals INC, listed on XNAS. He has 33 filings in total, and in the most recent filings we hold, purchases amount to EUR 181105 and sales to EUR 10589734, between 2021-09-10 and 2026-03-10, with the main transaction nature indicated as Tax withholding.
